Current Assets Endring Dato
Adcock Ingram Holdings ZAR 4.89B 194.86M 2024-06
Alnylam Pharmaceuticals USD 3.3B 60.14M 2024-12
Celltrion KRW 5.37T 121.47B 2024-09
Cspc Pharmaceutical CNY 26.47B 278.69M 2024-06
Dianthus Therapeutics USD 287.49M 78.2M 2024-09
Ecofibre AUD 37.37M 2.03M 2024-06
Gilead Sciences USD 19.17B 4.39B 2024-12
Ionis Pharmaceuticals USD 2.62B 93.56M 2024-12
Kangmei Pharma CNY 7.01B 15.81M 2024-09
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Laboratorios Farma EUR 540.78M 55.36M 2024-06
MacroGenics USD 222.2M 65.24M 2024-09
Malin Corporation EUR 35.9M 100K 2024-06
Medical Developments International AUD 26.14M 4.89M 2024-06
Neuren Pharmaceuticals AUD 399.33M 171.29M 2024-12
Organigram Holdings CAD 231.49M 30.73M 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Pharma Mar EUR 250.25M 12.23M 2024-12
Qiagen NV USD 1.96B 494.22M 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 30.08B 589M 2024-06
Sarepta Therapeutics USD 3.07B 388.09M 2024-12
Sartorius EUR 1.97B 114.6M 2024-09
Sino Biopharmaceutical CNY 25.22B 1.42B 2024-06
Takeda JPY 2.75T 299.73B 2024-12
Tilray USD 707.34M 18.54M 2024-11
Zz Pientze Pharmaceu 15.84B 718.65M 2024-09



Tectonic Therapeutic Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.